Fund Holdings — Alphabet Inc.

Total Portfolio Value:
$2.14B
Total Bought:
$2.59M
Total Sold:
$116.74M
Net Transaction:
-$114.15M
Securities
▲▼
SharesValue
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
AST SpaceMobile, Inc.CL A(ASTS)8,943,4868,943,4860$203.37M$417.93M19.57%+$214.55M
Arm Holdings PlcADS1,960,7841,960,7840$209.39M$317.14M14.85%+$107.75M
Freshworks Inc.CL A(FRSH)16,206,64316,206,6430$228.68M$241.64M11.32%+$12.97M
Planet Labs PBCCL A(PL)31,942,64131,942,6410$107.97M$194.85M9.13%+$86.88M
Revolution Medicines, Inc.(RVMD)4,133,2774,133,2770$146.15M$152.06M7.12%+$5.91M
Metsera Inc4,961,7444,961,7440$135.06M$141.16M6.61%+$6.10M
Verve Therapeutics Inc12,349,08612,168,489-180,597$56.44M$136.65M6.40%+$80.22M
GitLab Inc.CL A(GTLB)2,724,7122,724,7120$128.06M$122.91M5.76%-$5.15M
Tempus AI, Inc.CL A(TEM)1,551,1021,551,1020$74.83M$98.56M4.62%+$23.73M
DexCom, Inc.(DXCM)1,036,9371,036,9370$70.81M$90.51M4.24%+$19.70M
UiPath, Inc.CL A(PATH)7,034,3377,034,3370$72.45M$90.04M4.22%+$17.59M
Prime Medicine, Inc.(PRME)15,062,49815,062,4980$29.97M$37.20M1.74%+$7.23M
Maze Therapeutics, Inc.(MAZE)2,412,4712,412,4710$26.56M$29.60M1.39%+$3.04M
Oscar Health, Inc.CL A(OSCR)481,988481,9880$6.32M$10.33M0.48%+$4.01M
Sana Biotechnology, Inc.(SANA)2,812,5002,812,5000$4.72M$7.68M0.36%+$2.95M
Monte Rosa Therapeutics, Inc.(GLUE)1,464,0151,464,0150$6.79M$6.60M0.31%-$190.3K
Vera Therapeutics, Inc.CL A(VERA)241,264241,2640$5.80M$5.68M0.27%-$111.0K
Beam Therapeutics Inc.(BEAM)321,604321,6040$6.28M$5.47M0.26%-$810.4K
Relay Therapeutics, Inc.(RLAY)1,568,7531,568,7530$4.11M$5.43M0.25%+$1.32M
Dianthus Therapeutics, Inc.(DNTH)208,697208,6970$3.79M$3.89M0.18%+$102.3K
Lyell Immunopharma, Inc.(LYEL)0293,256+293,256$0$2.59M0.12%+$2.59M
Spero Therapeutics, Inc.(SPRO)889,979889,9790$640.8K$2.58M0.12%+$1.94M
Foghorn Therapeutics Inc.(FHTX)500,901500,9010$1.83M$2.35M0.11%+$525.9K
GeneDx Holdings Corp.(WGS)22,71122,7110$2.01M$2.10M0.10%+$84.9K
Autolus Therapeutics plcADS(AUTL)698,262698,2620$1.08M$1.59M0.07%+$509.7K
TScan Therapeutics, Inc.(TCRX)1,077,0801,077,0800$1.49M$1.56M0.07%+$75.4K
Taysha Gene Therapies, Inc.(TSHA)640,882640,8820$890.8K$1.48M0.07%+$589.6K
Barinthus Biotherapeutics PlADS1,513,6441,513,6440$1.47M$1.41M0.07%-$60.5K
Endeavour Silver Corp.(EXK)23,20523,2050$1.00M$1.23M0.06%+$228.6K
Fractyl Health, Inc.(GUTS)662,584662,5840$788.5K$1.07M0.05%+$284.9K
Hyperfine, Inc.CL A(HYPR)898,720898,7200$647.1K$647.1K0.03%$0
Tenaya Therapeutics, Inc.(TNYA)915,705915,7050$522.0K$558.6K0.03%+$36.6K
IRulya Therapeutics Inc.(IRLA)189,122189,1220$251.5K$312.1K0.01%+$60.5K
Alector Inc175,866175,8660$216.3K$246.2K0.01%+$29.9K
Fulcrum Therapeutics, Inc.(FULC)14,26214,2620$41.1K$98.1K0.00%+$57.0K
Repligen Corporation(RGEN)3833830$48.7K$47.6K0.00%-$1.1K
CrowdStrike Holdings, Inc.CL A(CRWD)74,2300-74,230$26.17M$0—-$26.17M
Desktop Metal IncCL A1,104,8710-1,104,871$5.42M$0—-$5.42M
Kronos Bio Inc1,438,2320-1,438,232$1.19M$0—-$1.19M
Lyell Immunopharma, Inc.(LYEL)5,865,1250-5,865,125$3.17M$0—-$3.17M
Rani Therapeutics Holdings, Inc.CL A(RANI)448,4920-448,492$565.1K$0—-$565.1K
Page 1 of 1
Alphabet Inc. — 13F Holdings — Q2 2025 | TickerTrail